Out of 2 analysts covering Neovasc Inc (NASDAQ:NVCN), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. $10 is the highest target while $9.25 is the lowest. The $9.63 average target is 1683.33% above today’s ($0.54) stock price. Neovasc Inc has been the topic of 3 analyst reports since October 7, 2015 according to StockzIntelligence Inc. Ladenburg Thalmann downgraded the stock on May 20 to “Neutral” rating. Below is a list of Neovasc Inc (US) (NASDAQ:NVCN) latest ratings and price target changes.
20/05/2016 Broker: Ladenburg Thalmann Old Rating: Buy New Rating: Neutral Downgrade
About 831,525 shares traded hands. Neovasc Inc (US) (NASDAQ:NVCN) has declined 82.88% since February 8, 2016 and is downtrending. It has underperformed by 99.37% the S&P500.
Neovasc Inc. is a specialty medical device company. The company has a market cap of $37.98 million. The Firm develops, makes and markets products for the cardiovascular marketplace. It currently has negative earnings. The Company’s segment is the development, manufacture and marketing of medical devices.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.